Cargando…

Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Detalles Bibliográficos
Autores principales:	Desai, Aakash, Gainor, Justin F., Hegde, Aparna, Schram, Alison M., Curigliano, Giuseppe, Pal, Sumanta, Liu, Stephen V., Halmos, Balazs, Groisberg, Roman, Grande, Enrique, Dragovich, Tomislav, Matrana, Marc, Agarwal, Neeraj, Chawla, Sant, Kato, Shumei, Morgan, Gilberto, Kasi, Pashtoon M., Solomon, Benjamin, Loong, Herbert H., Park, Haeseong, Choueiri, Toni K., Subbiah, Ishwaria M., Pemmaraju, Naveen, Subbiah, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985918/ https://www.ncbi.nlm.nih.gov/pubmed/33758378 http://dx.doi.org/10.1038/s41571-021-00503-2

Ejemplares similares

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Caring for the caregiver: a systematic review characterising the experience of caregivers of older adults with advanced cancers
por: Adashek, Jacob J, et al.
Publicado: (2020)

Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape
por: Subbiah, Ishwaria M., et al.
Publicado: (2017)

Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic
por: Dhawan, Natasha, et al.
Publicado: (2020)

Precision Oncology in Sarcomas: Divide and Conquer
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2019)

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
por: Adashek, Jacob J., et al.
Publicado: (2020)

Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors
por: Subbiah, Ishwaria M., et al.
Publicado: (2018)

Machine learning models for 180-day mortality prediction of patients with advanced cancer using patient-reported symptom data
por: Xu, Cai, et al.
Publicado: (2022)

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
por: Malla, Midhun, et al.
Publicado: (2022)

Association of Edmonton Symptom Assessment System Global Distress Score With Overall Survival in Patients With Advanced Cancer
por: Subbiah, Ishwaria M., et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Malignant Hyperthermia and Idiopathic HyperCKemia
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

The Use of Intravenous Neostigmine in Palliation of Severe Ileus
por: Kasi, Pashtoon Murtaza
Publicado: (2013)

Favorable Outcomes in FGFR Fusion-Positive Cholangiocarcinomas and Evolution on Treatment Noted on Circulating Tumor DNA Liquid Biopsies
por: Kasi, Pashtoon Murtaza
Publicado: (2020)

Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies
por: Kasi, Pashtoon Murtaza
Publicado: (2022)

Call for Adoption of Synchronized Biweekly Dosing of Anti-EGFR Agent Cetuximab: Implications for Patients with Metastatic Colorectal Cancer, and Squamous Cell Carcinoma of the Head and Neck
por: Kasi, Pashtoon Murtaza
Publicado: (2022)

Types of Liquid Biopsies: Understanding the Different Lenses Through Which They Can Detect Cancer
por: Kasi, Pashtoon Murtaza
Publicado: (2023)

Editorial: Case reports in gastrointestinal cancers : 2022
por: Kasi, Pashtoon Murtaza
Publicado: (2023)

Practice Patterns on the Incorporation of Integrative Medicine Into the Oncologic Care of Patients With Cancer
por: Narayanan, Santhosshi, et al.
Publicado: (2023)

Differentiating Recurrent Thyroiditis From Graves’ Disease on a Background of Lithium Use
por: Subbiah, Kasi, et al.
Publicado: (2021)

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
por: Dragovich, Tomislav, et al.
Publicado: (2009)

Healthcare Disparities and the COVID-19 Pandemic: Analysis of Primary Language and Translations of Visitor Policies at NCI-Designated Comprehensive Cancer Centers
por: Dhawan, Natasha, et al.
Publicado: (2021)

Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma
por: Subbiah, Ishwaria M., et al.
Publicado: (2014)

Rituximab and Cytokine Release Syndrome
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2012)

Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation–associated metastatic renal-cell carcinoma
por: Alsidawi, Samer, et al.
Publicado: (2018)

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge
por: Chennamadhavuni, Adithya, et al.
Publicado: (2022)

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021)

Visitation policies at NCI-designated comprehensive cancer centers during the COVID-19 pandemic
por: Yeh, Jonathan C., et al.
Publicado: (2021)

Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer
por: Swofford, Brenen P., et al.
Publicado: (2017)

Sigmoid Adenocarcinoma with Regional Scrotal Metastasis
por: Swofford, Brenen P., et al.
Publicado: (2017)

Neuroendocrine Tumor Involving the Epicardium
por: Soyano, Aixa E., et al.
Publicado: (2017)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019)

Expanding the Indication for Novel Theranostic 177Lu-Dotatate Peptide Receptor Radionuclide Therapy: Proof-of-Concept of PRRT in Merkel Cell Cancer
por: Kasi, Pashtoon M., et al.
Publicado: (2019)

Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy
por: Lutfi, Areeb, et al.
Publicado: (2023)

Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials
por: Subbiah, Ishwaria M., et al.
Publicado: (2015)

Birt-Hogg-Dubé Syndrome: Answering Questions Raised by a Case Report Published in 1962
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2011)

Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications
por: Chang, John, et al.
Publicado: (2015)

Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2013)

Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment
por: Subbiah, Ishwaria M., et al.
Publicado: (2022)

Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncology
por: Graff, Stephanie L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9563ksm6cejis829mufl7plcch